Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate‐mediated targeting in vitro and prolonged plasma circulation in vivo

Identifieur interne : 001291 ( Istex/Corpus ); précédent : 001290; suivant : 001292

Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate‐mediated targeting in vitro and prolonged plasma circulation in vivo

Auteurs : Christopher M. Ward ; Michal Pechar ; David Oupicky ; Karel Ulbrich ; Leonard W. Seymour

Source :

RBID : ISTEX:EC6797B8675BC0BBBA5E95555AAE701AD751F17C

English descriptors

Abstract

Background: Gene delivery vectors based on poly(L‐lysine) and DNA (pLL/DNA complexes) have limited use for targeted systemic application in vivo since they bind cells and proteins non‐specifically. In this study we have attempted to form folate‐targeted vectors with extended systemic circulation by surface modification of pLL/DNA complexes with hydrophilic polymers. Methods: pLL/DNA complexes were stabilised by surface modification with a multivalent reactive polymer based on alternating segments of poly(ethylene glycol) and tripeptides bearing reactive ester groups. Folate moieties were incorporated into the vectors either by direct attachment of folate to the polymer or via intermediate poly(ethylene glycol) spacers of 800 and 3400 Da. Results: Polymer‐coated complexes show similar morphology to uncoated complexes, their zeta potential is decreased towards zero, serum protein binding is inhibited and aqueous solubility is substantially increased. Intravenous (i.v.) administration to mice of coated complexes produced extended systemic circulation, with up to 2000‐fold more DNA measured in the bloodstream after 30 min compared with simple pLL/DNA complexes. In further contrast to simple pLL/DNA complexes, coated complexes do not bind blood cells in vivo. Folate receptor targeting is shown to mediate targeted association with HeLa cells in vitro, leading to increased transgene expression. We demonstrate for the first time that DNA uptake via the folate receptor is dependent on pEG spacer length, with the transgene expression relatively independent of the level of internalised DNA. Conclusions: We show increased systemic circulation, decreased blood cell and protein binding, and folate‐targeted transgene expression using pLL/DNA complexes surface‐modified with a novel multireactive hydrophilic polymer. This work provides the basis for the development of plasma‐circulating targeted vectors for in vivo applications. Copyright © 2002 John Wiley & Sons, Ltd.

Url:
DOI: 10.1002/jgm.296

Links to Exploration step

ISTEX:EC6797B8675BC0BBBA5E95555AAE701AD751F17C

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate‐mediated targeting in vitro and prolonged plasma circulation in vivo</title>
<author>
<name sortKey="Ward, Christopher M" sort="Ward, Christopher M" uniqKey="Ward C" first="Christopher M." last="Ward">Christopher M. Ward</name>
<affiliation>
<mods:affiliation>Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>E-mail: wardcm@hotmail.com</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Correspondence address: Immunology Group, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK.</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Pechar, Michal" sort="Pechar, Michal" uniqKey="Pechar M" first="Michal" last="Pechar">Michal Pechar</name>
<affiliation>
<mods:affiliation>Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Square, Prague 6, 16206, The Czech Republic</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Oupicky, David" sort="Oupicky, David" uniqKey="Oupicky D" first="David" last="Oupicky">David Oupicky</name>
<affiliation>
<mods:affiliation>CRC Institute for Cancer Studies, University of Birmingham, Birmingham B15 2TA, UK</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ulbrich, Karel" sort="Ulbrich, Karel" uniqKey="Ulbrich K" first="Karel" last="Ulbrich">Karel Ulbrich</name>
<affiliation>
<mods:affiliation>Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Square, Prague 6, 16206, The Czech Republic</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Seymour, Leonard W" sort="Seymour, Leonard W" uniqKey="Seymour L" first="Leonard W." last="Seymour">Leonard W. Seymour</name>
<affiliation>
<mods:affiliation>CRC Institute for Cancer Studies, University of Birmingham, Birmingham B15 2TA, UK</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:EC6797B8675BC0BBBA5E95555AAE701AD751F17C</idno>
<date when="2002" year="2002">2002</date>
<idno type="doi">10.1002/jgm.296</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-7KRBHKSQ-W/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001291</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001291</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate‐mediated targeting in vitro and prolonged plasma circulation in vivo</title>
<author>
<name sortKey="Ward, Christopher M" sort="Ward, Christopher M" uniqKey="Ward C" first="Christopher M." last="Ward">Christopher M. Ward</name>
<affiliation>
<mods:affiliation>Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>E-mail: wardcm@hotmail.com</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Correspondence address: Immunology Group, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK.</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Pechar, Michal" sort="Pechar, Michal" uniqKey="Pechar M" first="Michal" last="Pechar">Michal Pechar</name>
<affiliation>
<mods:affiliation>Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Square, Prague 6, 16206, The Czech Republic</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Oupicky, David" sort="Oupicky, David" uniqKey="Oupicky D" first="David" last="Oupicky">David Oupicky</name>
<affiliation>
<mods:affiliation>CRC Institute for Cancer Studies, University of Birmingham, Birmingham B15 2TA, UK</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ulbrich, Karel" sort="Ulbrich, Karel" uniqKey="Ulbrich K" first="Karel" last="Ulbrich">Karel Ulbrich</name>
<affiliation>
<mods:affiliation>Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Square, Prague 6, 16206, The Czech Republic</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Seymour, Leonard W" sort="Seymour, Leonard W" uniqKey="Seymour L" first="Leonard W." last="Seymour">Leonard W. Seymour</name>
<affiliation>
<mods:affiliation>CRC Institute for Cancer Studies, University of Birmingham, Birmingham B15 2TA, UK</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">The Journal of Gene Medicine</title>
<title level="j" type="alt">JOURNAL OF GENE MEDICINE, THE</title>
<idno type="ISSN">1099-498X</idno>
<idno type="eISSN">1521-2254</idno>
<imprint>
<biblScope unit="vol">4</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="536">536</biblScope>
<biblScope unit="page" to="547">547</biblScope>
<biblScope unit="page-count">12</biblScope>
<publisher>John Wiley & Sons, Ltd.</publisher>
<pubPlace>Chichester, UK</pubPlace>
<date type="published" when="2002-09">2002-09</date>
</imprint>
<idno type="ISSN">1099-498X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1099-498X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Acid binding</term>
<term>Albumin concentrations</term>
<term>Aliquot portions</term>
<term>Amersham pharmacia</term>
<term>Analyser</term>
<term>Aqueous solubility</term>
<term>Bind blood cells</term>
<term>Bioconjug chem</term>
<term>Biol chem</term>
<term>Blood cell</term>
<term>Blood cell binding</term>
<term>Blood cells</term>
<term>Body distribution</term>
<term>Cancer cells</term>
<term>Cancer research</term>
<term>Cationic polymer</term>
<term>Cell lines</term>
<term>Cellular uptake</term>
<term>Chem</term>
<term>Christie hospital</term>
<term>Circulation properties</term>
<term>Circulation times</term>
<term>Coating complexes</term>
<term>Competitive inhibition</term>
<term>Copper grids</term>
<term>Copyright</term>
<term>Covalent</term>
<term>Covalent linkage</term>
<term>Czech republic</term>
<term>Diethyl ether</term>
<term>Dos</term>
<term>Dose polymer</term>
<term>Ester</term>
<term>Expression vector</term>
<term>Folate</term>
<term>Folate conjugates</term>
<term>Folate receptor</term>
<term>Folate receptors</term>
<term>Folic</term>
<term>Folic acid</term>
<term>Free polymer</term>
<term>Fresh media</term>
<term>Gene delivery</term>
<term>Hela</term>
<term>Hela cells</term>
<term>Hepes buffer</term>
<term>High dose</term>
<term>High dose polymer</term>
<term>High dose polymer complexes</term>
<term>High doses</term>
<term>Higher doses</term>
<term>Human serum</term>
<term>Hydrolysed polymer</term>
<term>Hydrophilic polymers</term>
<term>Independent experiments</term>
<term>Integration time</term>
<term>Intravenous injection</term>
<term>John wiley sons</term>
<term>Lateral stabilisation</term>
<term>Liquid scintillation analyser</term>
<term>Luminescence spectrometer</term>
<term>Lysosomal cathepsins</term>
<term>Meantstandard deviation</term>
<term>Molecular weight sartorius</term>
<term>Multivalent</term>
<term>Nitrocellulose membrane</term>
<term>Ovarian cancer patients</term>
<term>Paterson institute</term>
<term>Plasma circulation</term>
<term>Plasma fraction</term>
<term>Polyelectrolyte</term>
<term>Polyelectrolyte complexes</term>
<term>Polymer</term>
<term>Polymer coating</term>
<term>Polymer complexes</term>
<term>Preformed complexes</term>
<term>Protein binding</term>
<term>Radioactivity assay</term>
<term>Rapid clearance</term>
<term>Reactive</term>
<term>Reactive esters</term>
<term>Receptor</term>
<term>Results show</term>
<term>Room temperature</term>
<term>Scintillation</term>
<term>Scintillation analyser</term>
<term>Serum protein binding</term>
<term>Serum proteins</term>
<term>Seymour</term>
<term>Simple complexes</term>
<term>Slit widths</term>
<term>Solid product</term>
<term>Spacer</term>
<term>Spacer length</term>
<term>Stock solution</term>
<term>Such vectors</term>
<term>Sucrose solution</term>
<term>Surface charge</term>
<term>Systemic circulation</term>
<term>Target cells</term>
<term>Total luciferase protein expression</term>
<term>Total protein concentration</term>
<term>Transfection</term>
<term>Transgene</term>
<term>Transgene expression</term>
<term>Transmission electron microscope</term>
<term>Transmission electron microscopy</term>
<term>Tumour cells</term>
<term>Turbidity</term>
<term>Turbidometric analysis</term>
<term>Ultracentrifuge tube</term>
<term>Untargeted complexes</term>
<term>Uptake</term>
<term>Uranyl acetate stain</term>
<term>Various concentrations</term>
<term>Vector surface</term>
<term>Vivo</term>
<term>Vivo applications</term>
<term>Vivo studies</term>
<term>Wilmslow road</term>
<term>Zeta</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Background: Gene delivery vectors based on poly(L‐lysine) and DNA (pLL/DNA complexes) have limited use for targeted systemic application in vivo since they bind cells and proteins non‐specifically. In this study we have attempted to form folate‐targeted vectors with extended systemic circulation by surface modification of pLL/DNA complexes with hydrophilic polymers. Methods: pLL/DNA complexes were stabilised by surface modification with a multivalent reactive polymer based on alternating segments of poly(ethylene glycol) and tripeptides bearing reactive ester groups. Folate moieties were incorporated into the vectors either by direct attachment of folate to the polymer or via intermediate poly(ethylene glycol) spacers of 800 and 3400 Da. Results: Polymer‐coated complexes show similar morphology to uncoated complexes, their zeta potential is decreased towards zero, serum protein binding is inhibited and aqueous solubility is substantially increased. Intravenous (i.v.) administration to mice of coated complexes produced extended systemic circulation, with up to 2000‐fold more DNA measured in the bloodstream after 30 min compared with simple pLL/DNA complexes. In further contrast to simple pLL/DNA complexes, coated complexes do not bind blood cells in vivo. Folate receptor targeting is shown to mediate targeted association with HeLa cells in vitro, leading to increased transgene expression. We demonstrate for the first time that DNA uptake via the folate receptor is dependent on pEG spacer length, with the transgene expression relatively independent of the level of internalised DNA. Conclusions: We show increased systemic circulation, decreased blood cell and protein binding, and folate‐targeted transgene expression using pLL/DNA complexes surface‐modified with a novel multireactive hydrophilic polymer. This work provides the basis for the development of plasma‐circulating targeted vectors for in vivo applications. Copyright © 2002 John Wiley & Sons, Ltd.</div>
</front>
</TEI>
<istex>
<corpusName>wiley</corpusName>
<keywords>
<teeft>
<json:string>polymer</json:string>
<json:string>hela</json:string>
<json:string>folate</json:string>
<json:string>hela cells</json:string>
<json:string>polymer complexes</json:string>
<json:string>transgene</json:string>
<json:string>turbidity</json:string>
<json:string>transgene expression</json:string>
<json:string>copyright</json:string>
<json:string>john wiley sons</json:string>
<json:string>chem</json:string>
<json:string>reactive</json:string>
<json:string>scintillation</json:string>
<json:string>receptor</json:string>
<json:string>zeta</json:string>
<json:string>folic</json:string>
<json:string>transfection</json:string>
<json:string>ester</json:string>
<json:string>analyser</json:string>
<json:string>polyelectrolyte</json:string>
<json:string>room temperature</json:string>
<json:string>covalent</json:string>
<json:string>gene delivery</json:string>
<json:string>plasma circulation</json:string>
<json:string>folate receptor</json:string>
<json:string>protein binding</json:string>
<json:string>folic acid</json:string>
<json:string>bioconjug chem</json:string>
<json:string>hydrolysed polymer</json:string>
<json:string>liquid scintillation analyser</json:string>
<json:string>seymour</json:string>
<json:string>dos</json:string>
<json:string>amersham pharmacia</json:string>
<json:string>meantstandard deviation</json:string>
<json:string>reactive esters</json:string>
<json:string>spacer length</json:string>
<json:string>circulation times</json:string>
<json:string>blood cells</json:string>
<json:string>various concentrations</json:string>
<json:string>results show</json:string>
<json:string>systemic circulation</json:string>
<json:string>multivalent</json:string>
<json:string>dose polymer</json:string>
<json:string>high dose</json:string>
<json:string>czech republic</json:string>
<json:string>polyelectrolyte complexes</json:string>
<json:string>cell lines</json:string>
<json:string>cancer research</json:string>
<json:string>acid binding</json:string>
<json:string>serum protein binding</json:string>
<json:string>circulation properties</json:string>
<json:string>hepes buffer</json:string>
<json:string>cationic polymer</json:string>
<json:string>folate receptors</json:string>
<json:string>simple complexes</json:string>
<json:string>competitive inhibition</json:string>
<json:string>surface charge</json:string>
<json:string>hydrophilic polymers</json:string>
<json:string>aliquot portions</json:string>
<json:string>albumin concentrations</json:string>
<json:string>intravenous injection</json:string>
<json:string>biol chem</json:string>
<json:string>independent experiments</json:string>
<json:string>spacer</json:string>
<json:string>uptake</json:string>
<json:string>vivo</json:string>
<json:string>serum proteins</json:string>
<json:string>transmission electron microscope</json:string>
<json:string>luminescence spectrometer</json:string>
<json:string>slit widths</json:string>
<json:string>integration time</json:string>
<json:string>solid product</json:string>
<json:string>transmission electron microscopy</json:string>
<json:string>copper grids</json:string>
<json:string>uranyl acetate stain</json:string>
<json:string>human serum</json:string>
<json:string>sucrose solution</json:string>
<json:string>ultracentrifuge tube</json:string>
<json:string>nitrocellulose membrane</json:string>
<json:string>diethyl ether</json:string>
<json:string>cellular uptake</json:string>
<json:string>folate conjugates</json:string>
<json:string>target cells</json:string>
<json:string>vector surface</json:string>
<json:string>fresh media</json:string>
<json:string>total protein concentration</json:string>
<json:string>total luciferase protein expression</json:string>
<json:string>blood cell binding</json:string>
<json:string>preformed complexes</json:string>
<json:string>covalent linkage</json:string>
<json:string>polymer coating</json:string>
<json:string>coating complexes</json:string>
<json:string>molecular weight sartorius</json:string>
<json:string>lysosomal cathepsins</json:string>
<json:string>rapid clearance</json:string>
<json:string>turbidometric analysis</json:string>
<json:string>expression vector</json:string>
<json:string>vivo applications</json:string>
<json:string>high doses</json:string>
<json:string>blood cell</json:string>
<json:string>free polymer</json:string>
<json:string>radioactivity assay</json:string>
<json:string>scintillation analyser</json:string>
<json:string>high dose polymer complexes</json:string>
<json:string>plasma fraction</json:string>
<json:string>bind blood cells</json:string>
<json:string>aqueous solubility</json:string>
<json:string>untargeted complexes</json:string>
<json:string>wilmslow road</json:string>
<json:string>tumour cells</json:string>
<json:string>body distribution</json:string>
<json:string>high dose polymer</json:string>
<json:string>lateral stabilisation</json:string>
<json:string>higher doses</json:string>
<json:string>cancer cells</json:string>
<json:string>ovarian cancer patients</json:string>
<json:string>such vectors</json:string>
<json:string>christie hospital</json:string>
<json:string>paterson institute</json:string>
<json:string>stock solution</json:string>
<json:string>vivo studies</json:string>
</teeft>
</keywords>
<author>
<json:item>
<name>Christopher M. Ward</name>
<affiliations>
<json:string>Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK</json:string>
<json:string>E-mail: wardcm@hotmail.com</json:string>
<json:string>Correspondence address: Immunology Group, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK.</json:string>
</affiliations>
</json:item>
<json:item>
<name>Michal Pechar</name>
<affiliations>
<json:string>Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Square, Prague 6, 16206, The Czech Republic</json:string>
</affiliations>
</json:item>
<json:item>
<name>David Oupicky</name>
<affiliations>
<json:string>CRC Institute for Cancer Studies, University of Birmingham, Birmingham B15 2TA, UK</json:string>
</affiliations>
</json:item>
<json:item>
<name>Karel Ulbrich</name>
<affiliations>
<json:string>Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Square, Prague 6, 16206, The Czech Republic</json:string>
</affiliations>
</json:item>
<json:item>
<name>Leonard W. Seymour</name>
<affiliations>
<json:string>CRC Institute for Cancer Studies, University of Birmingham, Birmingham B15 2TA, UK</json:string>
</affiliations>
</json:item>
</author>
<subject>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>vector</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>non‐viral</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>folate</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>targeted</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>plasma</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>polymer</value>
</json:item>
</subject>
<articleId>
<json:string>JGM296</json:string>
</articleId>
<arkIstex>ark:/67375/WNG-7KRBHKSQ-W</arkIstex>
<language>
<json:string>eng</json:string>
</language>
<originalGenre>
<json:string>article</json:string>
</originalGenre>
<abstract>Background: Gene delivery vectors based on poly(L‐lysine) and DNA (pLL/DNA complexes) have limited use for targeted systemic application in vivo since they bind cells and proteins non‐specifically. In this study we have attempted to form folate‐targeted vectors with extended systemic circulation by surface modification of pLL/DNA complexes with hydrophilic polymers. Methods: pLL/DNA complexes were stabilised by surface modification with a multivalent reactive polymer based on alternating segments of poly(ethylene glycol) and tripeptides bearing reactive ester groups. Folate moieties were incorporated into the vectors either by direct attachment of folate to the polymer or via intermediate poly(ethylene glycol) spacers of 800 and 3400 Da. Results: Polymer‐coated complexes show similar morphology to uncoated complexes, their zeta potential is decreased towards zero, serum protein binding is inhibited and aqueous solubility is substantially increased. Intravenous (i.v.) administration to mice of coated complexes produced extended systemic circulation, with up to 2000‐fold more DNA measured in the bloodstream after 30 min compared with simple pLL/DNA complexes. In further contrast to simple pLL/DNA complexes, coated complexes do not bind blood cells in vivo. Folate receptor targeting is shown to mediate targeted association with HeLa cells in vitro, leading to increased transgene expression. We demonstrate for the first time that DNA uptake via the folate receptor is dependent on pEG spacer length, with the transgene expression relatively independent of the level of internalised DNA. Conclusions: We show increased systemic circulation, decreased blood cell and protein binding, and folate‐targeted transgene expression using pLL/DNA complexes surface‐modified with a novel multireactive hydrophilic polymer. This work provides the basis for the development of plasma‐circulating targeted vectors for in vivo applications. Copyright © 2002 John Wiley & Sons, Ltd.</abstract>
<qualityIndicators>
<score>10</score>
<pdfWordCount>6622</pdfWordCount>
<pdfCharCount>41627</pdfCharCount>
<pdfVersion>1.3</pdfVersion>
<pdfPageCount>12</pdfPageCount>
<pdfPageSize>592 x 837 pts</pdfPageSize>
<pdfWordsPerPage>552</pdfWordsPerPage>
<pdfText>true</pdfText>
<refBibsNative>true</refBibsNative>
<abstractWordCount>274</abstractWordCount>
<abstractCharCount>1986</abstractCharCount>
<keywordCount>6</keywordCount>
</qualityIndicators>
<title>Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate‐mediated targeting in vitro and prolonged plasma circulation in vivo</title>
<pmid>
<json:string>12221647</json:string>
</pmid>
<genre>
<json:string>article</json:string>
</genre>
<host>
<title>The Journal of Gene Medicine</title>
<language>
<json:string>unknown</json:string>
</language>
<doi>
<json:string>10.1002/(ISSN)1521-2254</json:string>
</doi>
<issn>
<json:string>1099-498X</json:string>
</issn>
<eissn>
<json:string>1521-2254</json:string>
</eissn>
<publisherId>
<json:string>JGM</json:string>
</publisherId>
<volume>4</volume>
<issue>5</issue>
<pages>
<first>536</first>
<last>547</last>
<total>12</total>
</pages>
<genre>
<json:string>journal</json:string>
</genre>
<subject>
<json:item>
<value>Research Article</value>
</json:item>
<json:item>
<value>Research Articles</value>
</json:item>
</subject>
</host>
<namedEntities>
<unitex>
<date>
<json:string>1000</json:string>
<json:string>2002</json:string>
</date>
<geogName></geogName>
<orgName>
<json:string>Shearwater Corporation</json:string>
<json:string>Malvern Instruments</json:string>
<json:string>Sons, Ltd.</json:string>
<json:string>Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Square, Prague</json:string>
<json:string>Home Office</json:string>
<json:string>Sons, Ltd</json:string>
<json:string>Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Wilmslow Road, Manchester</json:string>
<json:string>CRC Institute for Cancer Studies, University of Birmingham, Birmingham B</json:string>
</orgName>
<orgName_funder></orgName_funder>
<orgName_provider></orgName_provider>
<persName>
<json:string>Christopher M. Ward</json:string>
<json:string>Results</json:string>
<json:string>John Wiley</json:string>
<json:string>David Oupicky</json:string>
<json:string>Leonard W. Seymour</json:string>
<json:string>Michal Pechar</json:string>
<json:string>Karel Ulbrich</json:string>
</persName>
<placeName>
<json:string>Germany</json:string>
<json:string>Huntsville</json:string>
<json:string>UK</json:string>
<json:string>Czech Republic</json:string>
<json:string>High Wycombe</json:string>
</placeName>
<ref_url></ref_url>
<ref_bibl>
<json:string>[4]</json:string>
<json:string>[7,8]</json:string>
<json:string>[12]</json:string>
<json:string>[18]</json:string>
<json:string>[6]</json:string>
<json:string>[11]</json:string>
<json:string>Luo et al. [23]</json:string>
<json:string>[8]</json:string>
<json:string>[1]</json:string>
<json:string>[10]</json:string>
<json:string>[12,17]</json:string>
<json:string>[16]</json:string>
<json:string>[3]</json:string>
<json:string>Ward et al.</json:string>
<json:string>[20]</json:string>
<json:string>[5]</json:string>
<json:string>[15]</json:string>
<json:string>Kaiser et al. [21]</json:string>
<json:string>[7]</json:string>
<json:string>[4,13]</json:string>
<json:string>[2]</json:string>
<json:string>[24]</json:string>
<json:string>[4,5]</json:string>
<json:string>[19]</json:string>
</ref_bibl>
<bibl></bibl>
</unitex>
</namedEntities>
<ark>
<json:string>ark:/67375/WNG-7KRBHKSQ-W</json:string>
</ark>
<categories>
<wos>
<json:string>1 - science</json:string>
<json:string>2 - medicine, research & experimental</json:string>
<json:string>2 - genetics & heredity</json:string>
<json:string>2 - biotechnology & applied microbiology</json:string>
</wos>
<scienceMetrix>
<json:string>1 - applied sciences</json:string>
<json:string>2 - enabling & strategic technologies</json:string>
<json:string>3 - biotechnology</json:string>
</scienceMetrix>
<scopus>
<json:string>1 - Health Sciences</json:string>
<json:string>2 - Medicine</json:string>
<json:string>3 - Genetics(clinical)</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Pharmacology, Toxicology and Pharmaceutics</json:string>
<json:string>3 - Drug Discovery</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Biochemistry, Genetics and Molecular Biology</json:string>
<json:string>3 - Genetics</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Biochemistry, Genetics and Molecular Biology</json:string>
<json:string>3 - Molecular Biology</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Biochemistry, Genetics and Molecular Biology</json:string>
<json:string>3 - Molecular Medicine</json:string>
</scopus>
<inist>
<json:string>1 - sciences appliquees, technologies et medecines</json:string>
<json:string>2 - sciences biologiques et medicales</json:string>
<json:string>3 - sciences biologiques fondamentales et appliquees. psychologie</json:string>
<json:string>4 - industries agroalimentaires</json:string>
</inist>
</categories>
<publicationDate>2002</publicationDate>
<copyrightDate>2002</copyrightDate>
<doi>
<json:string>10.1002/jgm.296</json:string>
</doi>
<id>EC6797B8675BC0BBBA5E95555AAE701AD751F17C</id>
<score>1</score>
<fulltext>
<json:item>
<extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/ark:/67375/WNG-7KRBHKSQ-W/fulltext.pdf</uri>
</json:item>
<json:item>
<extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/ark:/67375/WNG-7KRBHKSQ-W/bundle.zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/WNG-7KRBHKSQ-W/fulltext.tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main">Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate‐mediated targeting in vitro and prolonged plasma circulation in vivo</title>
<title level="a" type="short" xml:lang="en">Folate‐Targeted Polymer‐Mediated pLL/DNA</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>John Wiley & Sons, Ltd.</publisher>
<pubPlace>Chichester, UK</pubPlace>
<availability>
<licence>Copyright © 2002 John Wiley & Sons, Ltd.</licence>
</availability>
<date type="published" when="2002-09"></date>
</publicationStmt>
<notesStmt>
<note type="content-type" subtype="article" source="article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</note>
<note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note>
</notesStmt>
<sourceDesc>
<biblStruct type="article">
<analytic>
<title level="a" type="main">Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate‐mediated targeting in vitro and prolonged plasma circulation in vivo</title>
<title level="a" type="short" xml:lang="en">Folate‐Targeted Polymer‐Mediated pLL/DNA</title>
<author xml:id="author-0000" role="corresp">
<persName>
<forename type="first">Christopher M.</forename>
<surname>Ward</surname>
</persName>
<email>wardcm@hotmail.com</email>
<affiliation>
<orgName type="institution">Paterson Institute for Cancer Research</orgName>
<orgName type="institution">Christie Hospital NHS Trust</orgName>
<address>
<addrLine>Wilmslow Road</addrLine>
<addrLine>Manchester M20 4BX, UK</addrLine>
<country key="GB" xml:lang="en">UNITED KINGDOM</country>
</address>
</affiliation>
</author>
<author xml:id="author-0001">
<persName>
<forename type="first">Michal</forename>
<surname>Pechar</surname>
</persName>
<affiliation>
<orgName type="institution">Institute of Macromolecular Chemistry</orgName>
<orgName type="institution">Academy of Sciences of the Czech Republic</orgName>
<address>
<addrLine>Heyrovsky Square</addrLine>
<addrLine>Prague 6, 16206, The Czech Republic</addrLine>
<country key="CZ" xml:lang="en">CZECH REPUBLIC</country>
</address>
</affiliation>
</author>
<author xml:id="author-0002">
<persName>
<forename type="first">David</forename>
<surname>Oupicky</surname>
</persName>
<affiliation>
<orgName type="institution">CRC Institute for Cancer Studies</orgName>
<orgName type="institution">University of Birmingham</orgName>
<address>
<addrLine>Birmingham B15 2TA</addrLine>
<addrLine>UK</addrLine>
<country key="GB" xml:lang="en">UNITED KINGDOM</country>
</address>
</affiliation>
</author>
<author xml:id="author-0003">
<persName>
<forename type="first">Karel</forename>
<surname>Ulbrich</surname>
</persName>
<affiliation>
<orgName type="institution">Institute of Macromolecular Chemistry</orgName>
<orgName type="institution">Academy of Sciences of the Czech Republic</orgName>
<address>
<addrLine>Heyrovsky Square</addrLine>
<addrLine>Prague 6, 16206, The Czech Republic</addrLine>
<country key="CZ" xml:lang="en">CZECH REPUBLIC</country>
</address>
</affiliation>
</author>
<author xml:id="author-0004">
<persName>
<forename type="first">Leonard W.</forename>
<surname>Seymour</surname>
</persName>
<affiliation>
<orgName type="institution">CRC Institute for Cancer Studies</orgName>
<orgName type="institution">University of Birmingham</orgName>
<address>
<addrLine>Birmingham B15 2TA</addrLine>
<addrLine>UK</addrLine>
<country key="GB" xml:lang="en">UNITED KINGDOM</country>
</address>
</affiliation>
</author>
<idno type="istex">EC6797B8675BC0BBBA5E95555AAE701AD751F17C</idno>
<idno type="ark">ark:/67375/WNG-7KRBHKSQ-W</idno>
<idno type="DOI">10.1002/jgm.296</idno>
<idno type="unit">JGM296</idno>
<idno type="toTypesetVersion">file:JGM.JGM296.pdf</idno>
</analytic>
<monogr>
<title level="j" type="main">The Journal of Gene Medicine</title>
<title level="j" type="alt">JOURNAL OF GENE MEDICINE, THE</title>
<idno type="pISSN">1099-498X</idno>
<idno type="eISSN">1521-2254</idno>
<idno type="book-DOI">10.1002/(ISSN)1521-2254</idno>
<idno type="book-part-DOI">10.1002/jgm.v4:5</idno>
<idno type="product">JGM</idno>
<imprint>
<biblScope unit="vol">4</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="536">536</biblScope>
<biblScope unit="page" to="547">547</biblScope>
<biblScope unit="page-count">12</biblScope>
<publisher>John Wiley & Sons, Ltd.</publisher>
<pubPlace>Chichester, UK</pubPlace>
<date type="published" when="2002-09"></date>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<encodingDesc>
<schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef>
<appInfo>
<application ident="pub2tei" version="1.0.10" when="2019-12-20">
<label>pub2TEI-ISTEX</label>
<desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
<ref target="http://www.tei-c.org/">We use TEI</ref>
</desc>
</application>
</appInfo>
</encodingDesc>
<profileDesc>
<abstract xml:lang="en" style="main">
<head>Abstract</head>
<head>Background</head>
<p>Gene delivery vectors based on poly(
<hi rend="smallCaps">L</hi>
‐lysine) and DNA (pLL/DNA complexes) have limited use for targeted systemic application
<hi rend="italic">in vivo</hi>
since they bind cells and proteins non‐specifically. In this study we have attempted to form folate‐targeted vectors with extended systemic circulation by surface modification of pLL/DNA complexes with hydrophilic polymers.</p>
<head>Methods</head>
<p>pLL/DNA complexes were stabilised by surface modification with a multivalent reactive polymer based on alternating segments of poly(ethylene glycol) and tripeptides bearing reactive ester groups. Folate moieties were incorporated into the vectors either by direct attachment of folate to the polymer or via intermediate poly(ethylene glycol) spacers of 800 and 3400 Da.</p>
<head>Results</head>
<p>Polymer‐coated complexes show similar morphology to uncoated complexes, their zeta potential is decreased towards zero, serum protein binding is inhibited and aqueous solubility is substantially increased. Intravenous (i.v.) administration to mice of coated complexes produced extended systemic circulation, with up to 2000‐fold more DNA measured in the bloodstream after 30 min compared with simple pLL/DNA complexes. In further contrast to simple pLL/DNA complexes, coated complexes do not bind blood cells
<hi rend="italic">in vivo</hi>
. Folate receptor targeting is shown to mediate targeted association with HeLa cells
<hi rend="italic">in vitro</hi>
, leading to increased transgene expression. We demonstrate for the first time that DNA uptake via the folate receptor is dependent on pEG spacer length, with the transgene expression relatively independent of the level of internalised DNA.</p>
<head>Conclusions</head>
<p>We show increased systemic circulation, decreased blood cell and protein binding, and folate‐targeted transgene expression using pLL/DNA complexes surface‐modified with a novel multireactive hydrophilic polymer. This work provides the basis for the development of plasma‐circulating targeted vectors for
<hi rend="italic">in vivo</hi>
applications. Copyright © 2002 John Wiley & Sons, Ltd.</p>
</abstract>
<textClass>
<keywords xml:lang="en">
<term xml:id="kwd1">vector</term>
<term xml:id="kwd2">non‐viral</term>
<term xml:id="kwd3">folate</term>
<term xml:id="kwd4">targeted</term>
<term xml:id="kwd5">plasma</term>
<term xml:id="kwd6">polymer</term>
</keywords>
<keywords rend="articleCategory">
<term>Research Article</term>
</keywords>
<keywords rend="tocHeading1">
<term>Research Articles</term>
</keywords>
</textClass>
<langUsage>
<language ident="en"></language>
</langUsage>
</profileDesc>
<revisionDesc>
<change when="2019-12-20" who="#istex" xml:id="pub2tei">formatting</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/ark:/67375/WNG-7KRBHKSQ-W/fulltext.txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Wiley, elements deleted: body">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document>
<component version="2.0" type="serialArticle" xml:lang="en">
<header>
<publicationMeta level="product">
<publisherInfo>
<publisherName>John Wiley & Sons, Ltd.</publisherName>
<publisherLoc>Chichester, UK</publisherLoc>
</publisherInfo>
<doi registered="yes">10.1002/(ISSN)1521-2254</doi>
<issn type="print">1099-498X</issn>
<issn type="electronic">1521-2254</issn>
<idGroup>
<id type="product" value="JGM"></id>
</idGroup>
<titleGroup>
<title type="main" xml:lang="en" sort="JOURNAL OF GENE MEDICINE, THE">The Journal of Gene Medicine</title>
<title type="subtitle">A cross‐disciplinary journal for research on the science of gene transfer and its clinical applications</title>
<title type="short">J. Gene Med.</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="50">
<doi origin="wiley" registered="yes">10.1002/jgm.v4:5</doi>
<numberingGroup>
<numbering type="journalVolume" number="4">4</numbering>
<numbering type="journalIssue">5</numbering>
</numberingGroup>
<coverDate startDate="2002-09">September/October 2002</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="article" position="11" status="forIssue">
<doi origin="wiley" registered="yes">10.1002/jgm.296</doi>
<idGroup>
<id type="unit" value="JGM296"></id>
</idGroup>
<countGroup>
<count type="pageTotal" number="12"></count>
</countGroup>
<titleGroup>
<title type="articleCategory">Research Article</title>
<title type="tocHeading1">Research Articles</title>
</titleGroup>
<copyright ownership="publisher">Copyright © 2002 John Wiley & Sons, Ltd.</copyright>
<eventGroup>
<event type="manuscriptReceived" date="2002-01-14"></event>
<event type="manuscriptRevised" date="2002-04-05"></event>
<event type="manuscriptAccepted" date="2002-04-18"></event>
<event type="publishedOnlineEarlyUnpaginated" date="2002-06-11"></event>
<event type="firstOnline" date="2002-06-11"></event>
<event type="publishedOnlineFinalForm" date="2002-09-06"></event>
<event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.2 mode:FullText source:FullText result:FullText" date="2010-03-04"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-01-30"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-11-04"></event>
</eventGroup>
<numberingGroup>
<numbering type="pageFirst">536</numbering>
<numbering type="pageLast">547</numbering>
</numberingGroup>
<correspondenceTo>Immunology Group, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK.</correspondenceTo>
<linkGroup>
<link type="toTypesetVersion" href="file:JGM.JGM296.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta>
<countGroup>
<count type="figureTotal" number="7"></count>
<count type="tableTotal" number="0"></count>
<count type="referenceTotal" number="24"></count>
</countGroup>
<titleGroup>
<title type="main" xml:lang="en">Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate‐mediated targeting
<i>in vitro</i>
and prolonged plasma circulation
<i>in vivo</i>
</title>
<title type="short" xml:lang="en">Folate‐Targeted Polymer‐Mediated pLL/DNA</title>
</titleGroup>
<creators>
<creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes">
<personName>
<givenNames>Christopher M.</givenNames>
<familyName>Ward</familyName>
</personName>
<contactDetails>
<email>wardcm@hotmail.com</email>
</contactDetails>
</creator>
<creator xml:id="au2" creatorRole="author" affiliationRef="#af3">
<personName>
<givenNames>Michal</givenNames>
<familyName>Pechar</familyName>
</personName>
</creator>
<creator xml:id="au3" creatorRole="author" affiliationRef="#af2">
<personName>
<givenNames>David</givenNames>
<familyName>Oupicky</familyName>
</personName>
</creator>
<creator xml:id="au4" creatorRole="author" affiliationRef="#af3">
<personName>
<givenNames>Karel</givenNames>
<familyName>Ulbrich</familyName>
</personName>
</creator>
<creator xml:id="au5" creatorRole="author" affiliationRef="#af2">
<personName>
<givenNames>Leonard W.</givenNames>
<familyName>Seymour</familyName>
</personName>
</creator>
</creators>
<affiliationGroup>
<affiliation xml:id="af1" countryCode="GB" type="organization">
<unparsedAffiliation>Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af2" countryCode="GB" type="organization">
<unparsedAffiliation>CRC Institute for Cancer Studies, University of Birmingham, Birmingham B15 2TA, UK</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af3" countryCode="CZ" type="organization">
<unparsedAffiliation>Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Square, Prague 6, 16206, The Czech Republic</unparsedAffiliation>
</affiliation>
</affiliationGroup>
<keywordGroup xml:lang="en" type="author">
<keyword xml:id="kwd1">vector</keyword>
<keyword xml:id="kwd2">non‐viral</keyword>
<keyword xml:id="kwd3">folate</keyword>
<keyword xml:id="kwd4">targeted</keyword>
<keyword xml:id="kwd5">plasma</keyword>
<keyword xml:id="kwd6">polymer</keyword>
</keywordGroup>
<fundingInfo>
<fundingAgency>Cancer Research UK</fundingAgency>
</fundingInfo>
<abstractGroup>
<abstract type="main" xml:lang="en">
<title type="main">Abstract</title>
<section xml:id="abs1-1">
<title type="main">Background</title>
<p>Gene delivery vectors based on poly(
<sc>L</sc>
‐lysine) and DNA (pLL/DNA complexes) have limited use for targeted systemic application
<i>in vivo</i>
since they bind cells and proteins non‐specifically. In this study we have attempted to form folate‐targeted vectors with extended systemic circulation by surface modification of pLL/DNA complexes with hydrophilic polymers.</p>
</section>
<section xml:id="abs1-2">
<title type="main">Methods</title>
<p>pLL/DNA complexes were stabilised by surface modification with a multivalent reactive polymer based on alternating segments of poly(ethylene glycol) and tripeptides bearing reactive ester groups. Folate moieties were incorporated into the vectors either by direct attachment of folate to the polymer or via intermediate poly(ethylene glycol) spacers of 800 and 3400 Da.</p>
</section>
<section xml:id="abs1-3">
<title type="main">Results</title>
<p>Polymer‐coated complexes show similar morphology to uncoated complexes, their zeta potential is decreased towards zero, serum protein binding is inhibited and aqueous solubility is substantially increased. Intravenous (i.v.) administration to mice of coated complexes produced extended systemic circulation, with up to 2000‐fold more DNA measured in the bloodstream after 30 min compared with simple pLL/DNA complexes. In further contrast to simple pLL/DNA complexes, coated complexes do not bind blood cells
<i>in vivo</i>
. Folate receptor targeting is shown to mediate targeted association with HeLa cells
<i>in vitro</i>
, leading to increased transgene expression. We demonstrate for the first time that DNA uptake via the folate receptor is dependent on pEG spacer length, with the transgene expression relatively independent of the level of internalised DNA.</p>
</section>
<section xml:id="abs1-4">
<title type="main">Conclusions</title>
<p>We show increased systemic circulation, decreased blood cell and protein binding, and folate‐targeted transgene expression using pLL/DNA complexes surface‐modified with a novel multireactive hydrophilic polymer. This work provides the basis for the development of plasma‐circulating targeted vectors for
<i>in vivo</i>
applications. Copyright © 2002 John Wiley & Sons, Ltd.</p>
</section>
</abstract>
</abstractGroup>
</contentMeta>
</header>
</component>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo lang="en">
<title>Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate‐mediated targeting in vitro and prolonged plasma circulation in vivo</title>
</titleInfo>
<titleInfo type="abbreviated" lang="en">
<title>Folate‐Targeted Polymer‐Mediated pLL/DNA</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en">
<title>Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate‐mediated targeting in vitro and prolonged plasma circulation in vivo</title>
</titleInfo>
<name type="personal">
<namePart type="given">Christopher M.</namePart>
<namePart type="family">Ward</namePart>
<affiliation>Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK</affiliation>
<affiliation>E-mail: wardcm@hotmail.com</affiliation>
<affiliation>Correspondence address: Immunology Group, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK.</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Michal</namePart>
<namePart type="family">Pechar</namePart>
<affiliation>Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Square, Prague 6, 16206, The Czech Republic</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">David</namePart>
<namePart type="family">Oupicky</namePart>
<affiliation>CRC Institute for Cancer Studies, University of Birmingham, Birmingham B15 2TA, UK</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Karel</namePart>
<namePart type="family">Ulbrich</namePart>
<affiliation>Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Square, Prague 6, 16206, The Czech Republic</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Leonard W.</namePart>
<namePart type="family">Seymour</namePart>
<affiliation>CRC Institute for Cancer Studies, University of Birmingham, Birmingham B15 2TA, UK</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="article" displayLabel="article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</genre>
<originInfo>
<publisher>John Wiley & Sons, Ltd.</publisher>
<place>
<placeTerm type="text">Chichester, UK</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2002-09</dateIssued>
<dateCaptured encoding="w3cdtf">2002-01-14</dateCaptured>
<dateValid encoding="w3cdtf">2002-04-18</dateValid>
<copyrightDate encoding="w3cdtf">2002</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription>
<extent unit="figures">7</extent>
<extent unit="tables">0</extent>
<extent unit="references">24</extent>
</physicalDescription>
<abstract lang="en">Background: Gene delivery vectors based on poly(L‐lysine) and DNA (pLL/DNA complexes) have limited use for targeted systemic application in vivo since they bind cells and proteins non‐specifically. In this study we have attempted to form folate‐targeted vectors with extended systemic circulation by surface modification of pLL/DNA complexes with hydrophilic polymers. Methods: pLL/DNA complexes were stabilised by surface modification with a multivalent reactive polymer based on alternating segments of poly(ethylene glycol) and tripeptides bearing reactive ester groups. Folate moieties were incorporated into the vectors either by direct attachment of folate to the polymer or via intermediate poly(ethylene glycol) spacers of 800 and 3400 Da. Results: Polymer‐coated complexes show similar morphology to uncoated complexes, their zeta potential is decreased towards zero, serum protein binding is inhibited and aqueous solubility is substantially increased. Intravenous (i.v.) administration to mice of coated complexes produced extended systemic circulation, with up to 2000‐fold more DNA measured in the bloodstream after 30 min compared with simple pLL/DNA complexes. In further contrast to simple pLL/DNA complexes, coated complexes do not bind blood cells in vivo. Folate receptor targeting is shown to mediate targeted association with HeLa cells in vitro, leading to increased transgene expression. We demonstrate for the first time that DNA uptake via the folate receptor is dependent on pEG spacer length, with the transgene expression relatively independent of the level of internalised DNA. Conclusions: We show increased systemic circulation, decreased blood cell and protein binding, and folate‐targeted transgene expression using pLL/DNA complexes surface‐modified with a novel multireactive hydrophilic polymer. This work provides the basis for the development of plasma‐circulating targeted vectors for in vivo applications. Copyright © 2002 John Wiley & Sons, Ltd.</abstract>
<note type="funding">Cancer Research UK</note>
<subject lang="en">
<genre>keywords</genre>
<topic>vector</topic>
<topic>non‐viral</topic>
<topic>folate</topic>
<topic>targeted</topic>
<topic>plasma</topic>
<topic>polymer</topic>
</subject>
<relatedItem type="host">
<titleInfo>
<title>The Journal of Gene Medicine</title>
<subTitle>A cross‐disciplinary journal for research on the science of gene transfer and its clinical applications</subTitle>
</titleInfo>
<titleInfo type="abbreviated">
<title>J. Gene Med.</title>
</titleInfo>
<genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre>
<subject>
<genre>article-category</genre>
<topic>Research Article</topic>
<topic>Research Articles</topic>
</subject>
<identifier type="ISSN">1099-498X</identifier>
<identifier type="eISSN">1521-2254</identifier>
<identifier type="DOI">10.1002/(ISSN)1521-2254</identifier>
<identifier type="PublisherID">JGM</identifier>
<part>
<date>2002</date>
<detail type="volume">
<caption>vol.</caption>
<number>4</number>
</detail>
<detail type="issue">
<caption>no.</caption>
<number>5</number>
</detail>
<extent unit="pages">
<start>536</start>
<end>547</end>
<total>12</total>
</extent>
</part>
</relatedItem>
<relatedItem type="references" displayLabel="cit1">
<titleInfo>
<title>Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery</title>
</titleInfo>
<name type="personal">
<namePart type="given">PR</namePart>
<namePart type="family">Dash</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">ML</namePart>
<namePart type="family">Read</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">LB</namePart>
<namePart type="family">Barrett</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">MA</namePart>
<namePart type="family">Wolfert</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">LW</namePart>
<namePart type="family">Seymour</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Dash PR, Read ML, Barrett LB, Wolfert MA, Seymour LW. Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery. Gene Ther 1999; 6: 643–650.</note>
<part>
<date>1999</date>
<detail type="volume">
<caption>vol.</caption>
<number>6</number>
</detail>
<extent unit="pages">
<start>643</start>
<end>650</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Gene Ther</title>
</titleInfo>
<part>
<date>1999</date>
<detail type="volume">
<caption>vol.</caption>
<number>6</number>
</detail>
<extent unit="pages">
<start>643</start>
<end>650</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit2">
<titleInfo>
<title>Polyelectrolyte vectors for gene delivery: influence of cationic polymer on biophysical properties of complexes formed with DNA</title>
</titleInfo>
<name type="personal">
<namePart type="given">MA</namePart>
<namePart type="family">Wolfert</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">PR</namePart>
<namePart type="family">Dash</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">O</namePart>
<namePart type="family">Nazarova</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">D</namePart>
<namePart type="family">Oupicky</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">LW</namePart>
<namePart type="family">Seymour</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">S</namePart>
<namePart type="family">Smart</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J</namePart>
<namePart type="family">Strohalm</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">K</namePart>
<namePart type="family">Ulbrich</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Wolfert MA, Dash PR, Nazarova O, Oupicky D, Seymour LW, Smart S, Strohalm J, Ulbrich K. Polyelectrolyte vectors for gene delivery: influence of cationic polymer on biophysical properties of complexes formed with DNA. Bioconjug Chem 1999; 10: 993–1004.</note>
<part>
<date>1999</date>
<detail type="volume">
<caption>vol.</caption>
<number>10</number>
</detail>
<extent unit="pages">
<start>993</start>
<end>1004</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Bioconjug Chem</title>
</titleInfo>
<part>
<date>1999</date>
<detail type="volume">
<caption>vol.</caption>
<number>10</number>
</detail>
<extent unit="pages">
<start>993</start>
<end>1004</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit3">
<titleInfo>
<title>Systemic circulation of poly(L‐lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy</title>
</titleInfo>
<name type="personal">
<namePart type="given">CM</namePart>
<namePart type="family">Ward</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">ML</namePart>
<namePart type="family">Read</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">LW</namePart>
<namePart type="family">Seymour</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ward CM, Read ML, Seymour LW. Systemic circulation of poly(L‐lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy. Blood 2001; 97: 2221–2229.</note>
<part>
<date>2001</date>
<detail type="volume">
<caption>vol.</caption>
<number>97</number>
</detail>
<extent unit="pages">
<start>2221</start>
<end>2229</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Blood</title>
</titleInfo>
<part>
<date>2001</date>
<detail type="volume">
<caption>vol.</caption>
<number>97</number>
</detail>
<extent unit="pages">
<start>2221</start>
<end>2229</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit4">
<titleInfo>
<title>Decreased binding to proteins and cells of polymeric gene delivery vectors surface modified with a multivalent hydrophilic polymer and retargeting through attachment of transferring</title>
</titleInfo>
<name type="personal">
<namePart type="given">PR</namePart>
<namePart type="family">Dash</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">ML</namePart>
<namePart type="family">Read</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">KD</namePart>
<namePart type="family">Fisher</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">KA</namePart>
<namePart type="family">Howard</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">M</namePart>
<namePart type="family">Wolfert</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">D</namePart>
<namePart type="family">Oupicky</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">V</namePart>
<namePart type="family">Subr</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J</namePart>
<namePart type="family">Strohalm</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">K</namePart>
<namePart type="family">Ulbrich</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">LW</namePart>
<namePart type="family">Seymour</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Dash PR, Read ML, Fisher KD, Howard KA, Wolfert M, Oupicky D, Subr V, Strohalm J, Ulbrich K, Seymour LW. Decreased binding to proteins and cells of polymeric gene delivery vectors surface modified with a multivalent hydrophilic polymer and retargeting through attachment of transferring. J Biol Chem 2000; 275: 3793–3802.</note>
<part>
<date>2000</date>
<detail type="volume">
<caption>vol.</caption>
<number>275</number>
</detail>
<extent unit="pages">
<start>3793</start>
<end>3802</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J Biol Chem</title>
</titleInfo>
<part>
<date>2000</date>
<detail type="volume">
<caption>vol.</caption>
<number>275</number>
</detail>
<extent unit="pages">
<start>3793</start>
<end>3802</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit5">
<titleInfo>
<title>A versatile system for receptor‐mediated gene delivery permits increased entry of DNA into target cells, enhanced delivery to the nucleus and elevated rates of transgene expression</title>
</titleInfo>
<name type="personal">
<namePart type="given">KD</namePart>
<namePart type="family">Fisher</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">K</namePart>
<namePart type="family">Ulbrich</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">V</namePart>
<namePart type="family">Subr</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">CM</namePart>
<namePart type="family">Ward</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">V</namePart>
<namePart type="family">Mautner</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">D</namePart>
<namePart type="family">Blakey</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">LW</namePart>
<namePart type="family">Seymour</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Fisher KD, Ulbrich K, Subr V, Ward CM, Mautner V, Blakey D, Seymour LW. A versatile system for receptor‐mediated gene delivery permits increased entry of DNA into target cells, enhanced delivery to the nucleus and elevated rates of transgene expression. Gene Ther 2000; 7: 1337–1343.</note>
<part>
<date>2000</date>
<detail type="volume">
<caption>vol.</caption>
<number>7</number>
</detail>
<extent unit="pages">
<start>1337</start>
<end>1343</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Gene Ther</title>
</titleInfo>
<part>
<date>2000</date>
<detail type="volume">
<caption>vol.</caption>
<number>7</number>
</detail>
<extent unit="pages">
<start>1337</start>
<end>1343</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit6">
<titleInfo>
<title>Poly(ethylene glycol) multiblock copolymer as a carrier of anti‐cancer drug doxorubicin</title>
</titleInfo>
<name type="personal">
<namePart type="given">M</namePart>
<namePart type="family">Pechar</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">K</namePart>
<namePart type="family">Ulbrich</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">V</namePart>
<namePart type="family">Subr</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">LW</namePart>
<namePart type="family">Seymour</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">EH</namePart>
<namePart type="family">Schacht</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Pechar M, Ulbrich K, Subr V, Seymour LW, Schacht EH. Poly(ethylene glycol) multiblock copolymer as a carrier of anti‐cancer drug doxorubicin. Bioconjug Chem 2000; 11: 131–139.</note>
<part>
<date>2000</date>
<detail type="volume">
<caption>vol.</caption>
<number>11</number>
</detail>
<extent unit="pages">
<start>131</start>
<end>139</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Bioconjug Chem</title>
</titleInfo>
<part>
<date>2000</date>
<detail type="volume">
<caption>vol.</caption>
<number>11</number>
</detail>
<extent unit="pages">
<start>131</start>
<end>139</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit7">
<titleInfo>
<title>Folate‐mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells</title>
</titleInfo>
<name type="personal">
<namePart type="given">S</namePart>
<namePart type="family">Wang</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">PS</namePart>
<namePart type="family">Low</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Wang S, Low PS. Folate‐mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells. J Controlled Release 1998; 53: 39–48.</note>
<part>
<date>1998</date>
<detail type="volume">
<caption>vol.</caption>
<number>53</number>
</detail>
<extent unit="pages">
<start>39</start>
<end>48</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J Controlled Release</title>
</titleInfo>
<part>
<date>1998</date>
<detail type="volume">
<caption>vol.</caption>
<number>53</number>
</detail>
<extent unit="pages">
<start>39</start>
<end>48</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit8">
<titleInfo>
<title>Cytotoxicity of momordin‐folate conjugates in cultured human cells</title>
</titleInfo>
<name type="personal">
<namePart type="given">CP</namePart>
<namePart type="family">Leamon</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">P</namePart>
<namePart type="family">Low</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Leamon CP, Low P. Cytotoxicity of momordin‐folate conjugates in cultured human cells. J Biol Chem 1992; 267: 24966–24971.</note>
<part>
<date>1992</date>
<detail type="volume">
<caption>vol.</caption>
<number>267</number>
</detail>
<extent unit="pages">
<start>24966</start>
<end>24971</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J Biol Chem</title>
</titleInfo>
<part>
<date>1992</date>
<detail type="volume">
<caption>vol.</caption>
<number>267</number>
</detail>
<extent unit="pages">
<start>24966</start>
<end>24971</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit9">
<titleInfo>
<title>The contribution of poly‐L‐lysine, epidermal growth factor and streptavidin to EGF/PLL/DNA polyplex formation</title>
</titleInfo>
<name type="personal">
<namePart type="given">B</namePart>
<namePart type="family">Xu</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">S</namePart>
<namePart type="family">Wiehle</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">JA</namePart>
<namePart type="family">Roth</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">RJ</namePart>
<namePart type="family">Cristiano</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Xu B, Wiehle S, Roth JA, Cristiano RJ. The contribution of poly‐L‐lysine, epidermal growth factor and streptavidin to EGF/PLL/DNA polyplex formation. Gene Ther 1998; 5: 1235–1243.</note>
<part>
<date>1998</date>
<detail type="volume">
<caption>vol.</caption>
<number>5</number>
</detail>
<extent unit="pages">
<start>1235</start>
<end>1243</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Gene Ther</title>
</titleInfo>
<part>
<date>1998</date>
<detail type="volume">
<caption>vol.</caption>
<number>5</number>
</detail>
<extent unit="pages">
<start>1235</start>
<end>1243</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit10">
<titleInfo>
<title>Turbidometric analysis of polyelectrolyte complexes formed between poly(L‐lysine) and DNA</title>
</titleInfo>
<name type="personal">
<namePart type="given">CM</namePart>
<namePart type="family">Ward</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">KD</namePart>
<namePart type="family">Fisher</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">LW</namePart>
<namePart type="family">Seymour</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ward CM, Fisher KD, Seymour LW. Turbidometric analysis of polyelectrolyte complexes formed between poly(L‐lysine) and DNA. Colloids Surfaces B 1999; 16: 253–260.</note>
<part>
<date>1999</date>
<detail type="volume">
<caption>vol.</caption>
<number>16</number>
</detail>
<extent unit="pages">
<start>253</start>
<end>260</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Colloids Surfaces B</title>
</titleInfo>
<part>
<date>1999</date>
<detail type="volume">
<caption>vol.</caption>
<number>16</number>
</detail>
<extent unit="pages">
<start>253</start>
<end>260</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit11">
<titleInfo>
<title>Folate copolymer‐mediated transfection of cultured cells</title>
</titleInfo>
<name type="personal">
<namePart type="given">CP</namePart>
<namePart type="family">Leamon</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">D</namePart>
<namePart type="family">Weigl</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">RW</namePart>
<namePart type="family">Hendren</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Leamon CP, Weigl D, Hendren RW. Folate copolymer‐mediated transfection of cultured cells. Bioconjug Chem 1999; 10: 947–957.</note>
<part>
<date>1999</date>
<detail type="volume">
<caption>vol.</caption>
<number>10</number>
</detail>
<extent unit="pages">
<start>947</start>
<end>957</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Bioconjug Chem</title>
</titleInfo>
<part>
<date>1999</date>
<detail type="volume">
<caption>vol.</caption>
<number>10</number>
</detail>
<extent unit="pages">
<start>947</start>
<end>957</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit12">
<titleInfo>
<title>Delivery of liposomes into cultured KB cells via folate‐receptor mediated endocytosis</title>
</titleInfo>
<name type="personal">
<namePart type="given">RJ</namePart>
<namePart type="family">Lee</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">PS</namePart>
<namePart type="family">Low</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Lee RJ, Low PS. Delivery of liposomes into cultured KB cells via folate‐receptor mediated endocytosis. J Biol Chem 1994; 269: 3198–3204.</note>
<part>
<date>1994</date>
<detail type="volume">
<caption>vol.</caption>
<number>269</number>
</detail>
<extent unit="pages">
<start>3198</start>
<end>3204</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J Biol Chem</title>
</titleInfo>
<part>
<date>1994</date>
<detail type="volume">
<caption>vol.</caption>
<number>269</number>
</detail>
<extent unit="pages">
<start>3198</start>
<end>3204</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit13">
<titleInfo>
<title>PEGylated DNA/transferrin‐PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery</title>
</titleInfo>
<name type="personal">
<namePart type="given">M</namePart>
<namePart type="family">Ogris</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">S</namePart>
<namePart type="family">Brunner</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">S</namePart>
<namePart type="family">Schuller</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">R</namePart>
<namePart type="family">Kircheis</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">E</namePart>
<namePart type="family">Wagner</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ogris M, Brunner S, Schuller S, Kircheis R, Wagner E. PEGylated DNA/transferrin‐PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther 1999; 6: 595–605.</note>
<part>
<date>1999</date>
<detail type="volume">
<caption>vol.</caption>
<number>6</number>
</detail>
<extent unit="pages">
<start>595</start>
<end>605</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Gene Ther</title>
</titleInfo>
<part>
<date>1999</date>
<detail type="volume">
<caption>vol.</caption>
<number>6</number>
</detail>
<extent unit="pages">
<start>595</start>
<end>605</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit14">
<titleInfo>
<title>Steric stabilization of poly‐L‐Lysine/DNA complexes by the covalent attachment of semitelechelic poly[N‐(2‐hydroxypropyl)methacrylamide]</title>
</titleInfo>
<name type="personal">
<namePart type="given">D</namePart>
<namePart type="family">Oupicky</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">KA</namePart>
<namePart type="family">Howard</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">C</namePart>
<namePart type="family">Konak</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">PR</namePart>
<namePart type="family">Dash</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">K</namePart>
<namePart type="family">Ulbrich</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">LW</namePart>
<namePart type="family">Seymour</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Oupicky D, Howard KA, Konak C, Dash PR, Ulbrich K, Seymour LW. Steric stabilization of poly‐L‐Lysine/DNA complexes by the covalent attachment of semitelechelic poly[N‐(2‐hydroxypropyl)methacrylamide]. Bioconjug Chem 2000; 11: 492–501.</note>
<part>
<date>2000</date>
<detail type="volume">
<caption>vol.</caption>
<number>11</number>
</detail>
<extent unit="pages">
<start>492</start>
<end>501</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Bioconjug Chem</title>
</titleInfo>
<part>
<date>2000</date>
<detail type="volume">
<caption>vol.</caption>
<number>11</number>
</detail>
<extent unit="pages">
<start>492</start>
<end>501</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit15">
<titleInfo>
<title>Interactions of C‐reactive protein with the complement system. II. C‐reactive protein‐mediated consumption of complement by poly‐L‐lysine polymers and other polycations</title>
</titleInfo>
<name type="personal">
<namePart type="given">J</namePart>
<namePart type="family">Siegal</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">MF</namePart>
<namePart type="family">Wilson</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">H</namePart>
<namePart type="family">Gewurz</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Siegal J, Wilson MF, Gewurz H. Interactions of C‐reactive protein with the complement system. II. C‐reactive protein‐mediated consumption of complement by poly‐L‐lysine polymers and other polycations. J Exp Med 1975; 142: 709–721.</note>
<part>
<date>1975</date>
<detail type="volume">
<caption>vol.</caption>
<number>142</number>
</detail>
<extent unit="pages">
<start>709</start>
<end>721</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J Exp Med</title>
</titleInfo>
<part>
<date>1975</date>
<detail type="volume">
<caption>vol.</caption>
<number>142</number>
</detail>
<extent unit="pages">
<start>709</start>
<end>721</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit16">
<titleInfo>
<title>Folate‐targeted non‐viral DNA vectors for cancer gene therapy</title>
</titleInfo>
<name type="personal">
<namePart type="given">CM</namePart>
<namePart type="family">Ward</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ward CM. Folate‐targeted non‐viral DNA vectors for cancer gene therapy. Curr Opin Mol Ther 2000; 2: 182–185.</note>
<part>
<date>2000</date>
<detail type="volume">
<caption>vol.</caption>
<number>2</number>
</detail>
<extent unit="pages">
<start>182</start>
<end>185</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Curr Opin Mol Ther</title>
</titleInfo>
<part>
<date>2000</date>
<detail type="volume">
<caption>vol.</caption>
<number>2</number>
</detail>
<extent unit="pages">
<start>182</start>
<end>185</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit17">
<titleInfo>
<title>Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)‐grafted liposomes: in vitro studies</title>
</titleInfo>
<name type="personal">
<namePart type="given">A</namePart>
<namePart type="family">Gabizon</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">AT</namePart>
<namePart type="family">Horowitz</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">D</namePart>
<namePart type="family">Goren</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">D</namePart>
<namePart type="family">Tzemach</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">F</namePart>
<namePart type="family">Mandelbaum‐Shavit</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">MM</namePart>
<namePart type="family">Qazen</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">S</namePart>
<namePart type="family">Zalipsky</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Gabizon A, Horowitz AT, Goren D, Tzemach D, Mandelbaum‐Shavit F, Qazen MM, Zalipsky S. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)‐grafted liposomes: in vitro studies. Bioconjug Chem 1999; 10: 289–298.</note>
<part>
<date>1999</date>
<detail type="volume">
<caption>vol.</caption>
<number>10</number>
</detail>
<extent unit="pages">
<start>289</start>
<end>298</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Bioconjug Chem</title>
</titleInfo>
<part>
<date>1999</date>
<detail type="volume">
<caption>vol.</caption>
<number>10</number>
</detail>
<extent unit="pages">
<start>289</start>
<end>298</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit18">
<titleInfo>
<title>PhD thesis</title>
</titleInfo>
<name type="personal">
<namePart type="given">CM</namePart>
<namePart type="family">Ward</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>other</genre>
<part>
<date>2000</date>
</part>
</relatedItem>
<relatedItem type="references" displayLabel="cit19">
<titleInfo>
<title>Folic acid targeting of protein conjugates into ascites tumour cells from ovarian cancer patients</title>
</titleInfo>
<name type="personal">
<namePart type="given">CM</namePart>
<namePart type="family">Ward</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">N</namePart>
<namePart type="family">Acheson</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">LW</namePart>
<namePart type="family">Seymour</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ward CM, Acheson N, Seymour LW. Folic acid targeting of protein conjugates into ascites tumour cells from ovarian cancer patients. J Drug Target 2000; 8: 119–123.</note>
<part>
<date>2000</date>
<detail type="volume">
<caption>vol.</caption>
<number>8</number>
</detail>
<extent unit="pages">
<start>119</start>
<end>123</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J Drug Target</title>
</titleInfo>
<part>
<date>2000</date>
<detail type="volume">
<caption>vol.</caption>
<number>8</number>
</detail>
<extent unit="pages">
<start>119</start>
<end>123</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit20">
<titleInfo>
<title>Influence of dose on liposome clearance: critical role of blood proteins</title>
</titleInfo>
<name type="personal">
<namePart type="given">CD</namePart>
<namePart type="family">Oja</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">SC</namePart>
<namePart type="family">Semple</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">A</namePart>
<namePart type="family">Chonn</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">PR</namePart>
<namePart type="family">Cullis</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Oja CD, Semple SC, Chonn A, Cullis PR. Influence of dose on liposome clearance: critical role of blood proteins. Biochim Biophys Acta Biomembranes 1996; 1281: 31–37.</note>
<part>
<date>1996</date>
<detail type="volume">
<caption>vol.</caption>
<number>1281</number>
</detail>
<extent unit="pages">
<start>31</start>
<end>37</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Biochim Biophys Acta Biomembranes</title>
</titleInfo>
<part>
<date>1996</date>
<detail type="volume">
<caption>vol.</caption>
<number>1281</number>
</detail>
<extent unit="pages">
<start>31</start>
<end>37</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit21">
<titleInfo>
<title>Basic studies on heterobifunctional biotin‐PEG conjugates with a 3‐(4‐pyridyldithio)propionyl marker on the second terminus</title>
</titleInfo>
<name type="personal">
<namePart type="given">K</namePart>
<namePart type="family">Kaiser</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">M</namePart>
<namePart type="family">Marek</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">T</namePart>
<namePart type="family">Haselgrubler</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">H</namePart>
<namePart type="family">Schindler</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">HJ</namePart>
<namePart type="family">Gruber</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Kaiser K, Marek M, Haselgrubler T, Schindler H, Gruber HJ. Basic studies on heterobifunctional biotin‐PEG conjugates with a 3‐(4‐pyridyldithio)propionyl marker on the second terminus. Bioconjug Chem 1997; 8: 545–551.</note>
<part>
<date>1997</date>
<detail type="volume">
<caption>vol.</caption>
<number>8</number>
</detail>
<extent unit="pages">
<start>545</start>
<end>551</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Bioconjug Chem</title>
</titleInfo>
<part>
<date>1997</date>
<detail type="volume">
<caption>vol.</caption>
<number>8</number>
</detail>
<extent unit="pages">
<start>545</start>
<end>551</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit22">
<titleInfo>
<title>Guidance on the Operation of the Animals (Scientific Procedures) Act 1986</title>
</titleInfo>
<name type="corporate">
<namePart>Home Office</namePart>
</name>
<genre>other</genre>
<part>
<date>1990</date>
</part>
</relatedItem>
<relatedItem type="references" displayLabel="cit23">
<titleInfo>
<title>Efficient syntheses of pyrofolic acid and pteroyl azide, reagents for the production of carboxyl‐differentiated derivatives of folic acid</title>
</titleInfo>
<name type="personal">
<namePart type="given">J</namePart>
<namePart type="family">Luo</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">MD</namePart>
<namePart type="family">Smith</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">DA</namePart>
<namePart type="family">Lantrip</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">S</namePart>
<namePart type="family">Wang</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">PL</namePart>
<namePart type="family">Fuchs</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Luo J, Smith MD, Lantrip DA, Wang S, Fuchs PL. Efficient syntheses of pyrofolic acid and pteroyl azide, reagents for the production of carboxyl‐differentiated derivatives of folic acid. J Am Chem Soc 1997; 119: 10004–10013.</note>
<part>
<date>1997</date>
<detail type="volume">
<caption>vol.</caption>
<number>119</number>
</detail>
<extent unit="pages">
<start>10004</start>
<end>10013</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J Am Chem Soc</title>
</titleInfo>
<part>
<date>1997</date>
<detail type="volume">
<caption>vol.</caption>
<number>119</number>
</detail>
<extent unit="pages">
<start>10004</start>
<end>10013</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit24">
<titleInfo>
<title>Laterally stabilized complexes of DNA with linear reducible polycations: strategy for triggered intracellular activation of DNA delivery vectors</title>
</titleInfo>
<name type="personal">
<namePart type="given">D</namePart>
<namePart type="family">Oupicky</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">AL</namePart>
<namePart type="family">Parker</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">LW</namePart>
<namePart type="family">Seymour</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Oupicky D, Parker AL, Seymour LW. Laterally stabilized complexes of DNA with linear reducible polycations: strategy for triggered intracellular activation of DNA delivery vectors. J Am Chem Soc 2002; 124: 8–9.</note>
<part>
<date>2002</date>
<detail type="volume">
<caption>vol.</caption>
<number>124</number>
</detail>
<extent unit="pages">
<start>8</start>
<end>9</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J Am Chem Soc</title>
</titleInfo>
<part>
<date>2002</date>
<detail type="volume">
<caption>vol.</caption>
<number>124</number>
</detail>
<extent unit="pages">
<start>8</start>
<end>9</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<identifier type="istex">EC6797B8675BC0BBBA5E95555AAE701AD751F17C</identifier>
<identifier type="ark">ark:/67375/WNG-7KRBHKSQ-W</identifier>
<identifier type="DOI">10.1002/jgm.296</identifier>
<identifier type="ArticleID">JGM296</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Copyright © 2002 John Wiley & Sons, Ltd.</accessCondition>
<recordInfo>
<recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource>
<recordOrigin>Converted from (version ) to MODS version 3.6.</recordOrigin>
<recordCreationDate encoding="w3cdtf">2019-11-15</recordCreationDate>
</recordInfo>
</mods>
<json:item>
<extension>json</extension>
<original>false</original>
<mimetype>application/json</mimetype>
<uri>https://api.istex.fr/ark:/67375/WNG-7KRBHKSQ-W/record.json</uri>
</json:item>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001291 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001291 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:EC6797B8675BC0BBBA5E95555AAE701AD751F17C
   |texte=   Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate‐mediated targeting in vitro and prolonged plasma circulation in vivo
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021